Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Concert Pharmaceuticals Successfully Completes CTP-543 Open Label Trial

americanpharmaceuticalreviewDecember 24, 2019

Tag: Concert , CTP-543 , Alopecia areata

PharmaSources Customer Service